INTRODUCTION
Tigerstedt and Bergman [l] showed, in 1898, that extracts of rabbit kidney cortex contained a vasopressor substance which they named renin. It was subsequently established that renin is an enzyme which acts upon a substrate of high MI, angiotensinogen, which is produced mainly by the liver. Renin catalyses the cleavage of the decapeptide angiotensin I (ANG I) from the substrate. The physiologically active product, angiotensin I1 (ANG 11) [2] , emerges after removal of the two endterminal amino acids by an angiotensin-converting enzyme (ACE), which is located mainly on the surface of endothelial cells [3]. The effects of ANG I1 are initiated after binding of the peptide to specific receptors, of which two subtypes have been identified (AT-1 and AT-2) [4] . ANG I1 affects blood pressure in a number of ways: by increasing total vascular resistance by direct effects on the resistance vessels, and by facilitation of sympathetic nerve transmission. Excretion of salt and water is influenced by stimulation of the adrenal production of aldosterone and by effects on renal proximal tubules, glomerular arterioles and renal medullary blood flow [S] . In addition, ANG I1 has a stimulatory effect on the thirst centre in the central nervous system (CNS) [6] . More recently, the reninangiotensin system (RAS) has received attention as a local growth factor that may be involved in the pathogenesis of hypertrophy of heart [7] and blood vessels during chronic heart failure and hypertension. The RAS thus plays an important role in the control of blood pressure and extracellular fluid homoeostasis.
In spite of the existence of local renin systems in various tissues (e.g. reproductive organs, CNS), the concentration of active renin in plasma is determined mainly by the rate of renin secretion from the kidneys, which are the only organs that contain substantial amounts of readily releasable active renin. Clinical interest in the RAS has grown after it was shown that pharmacological intervention (ACE inhibitors) has effects on essential hypertension and congestive heart failure.
Sk@t and B. L. lensen
renin, which consists of 406 amino acids [ 111. During transfer to the endoplasmic reticulum, the signal peptide (20 amino acids) is cleaved off, and the molecule is glycosylated [9] . The glycosylation affects the biological half-time of the molecule [ 161, but may also slow down the processing of prorenin to renin [9] . The pro-part of the molecule forms a plug in the cleft between the two lobes of the molecule and hinders the admission of renin substrate to the catalytic site. After transfer to the Golgi apparatus, prorenin is packed into protogranules that pinch off the trans-most Golgi cisterns. A part of the protogranules is not modified any further and proceeds to be secreted as prorenin via the constitutive pathway [17] , whereas others coalesce to form larger secretory granules. As mentioned above, the renin molecule is related to lysosoma1 enzymes, and the renin-containing secretory granules have several characteristics in common with lysosomes [18] : they have an acid pH and they contain typical lysosomal enzymes such as cathepsins B and D, acid phosphatase and / Iglucuronidase. These enzymes, most probably cathepsin B [19] , assist in the removal of the prosegment from the renin molecule, thereby exposing the active site. Consequently, the amount of active renin increases while the granules mature, whereas the amount of prorenin decreases [S, 201.
The secretory mechanism has been the subject of several studies. Thus, it has been shown that renin release from rat afferent arterioles in uitro occurs as a quanta1 event with an amount of renin discharged per episode which corresponds to the calculated values for the renin contents of single juxtaglomerular (JG) cell granules (about 1 million renin molecules per granule) [21] . Punctiform sites of fusion between the cell and granule membrane are observed after stimulation of secretion in uivo [22J The observations strongly suggest that renin secretory granules are secreted by exocytosis. The secretory events occur with the same probability at the luminal and abluminal side of the cells.
The mature renin granules constitute a store of active renin which is secreted in a regulated fashion. The rate of prorenin release by the constitutive pathway seems to depend on the transcription rate of the renin gene. In human plasma all of the active renin comes from the kidney. After 'activation' of plasma (e.g. treatment with trypsin), the renin activity is increased by a factor of 10. A large proportion of this inactive renin is prorenin. After nephrectomy the active renin disappears from the blood, whereas the concentration of inactive renin activity is halved. In rats, similar findings have been reported, but here it has been shown that the 'inactive renin' remaining after nephrectomy is neither prorenin nor renin [23] , suggesting that all prorenin also comes from the kidney.
The physiological significance of plasma prorenin has not been clarified. It has been suggested that the circulating inactive renin is a pool from which tissue-specific enzymes could recruit active renin with local effect. Although several procedures in uitro have proved capable of activating renin (cold, acidic pH and proteolytic digestion), the experimental evidence for such activation in uivo is still lacking [24] .
MORPHOLOGY
The majority of renal renin is synthesized, stored and released by cells located in the afferent arteriole normally close to the entry into the renal corpuscle. The cells containing renin (JG/epithelioid/reninpositive cells) are developed by metaplastic transformation of smooth muscle cells in the lamina media of the arteriolar wall. The JG cells have a welldeveloped secretory machinery: large nucleus, distinct endoplasmic reticulum and Golgi complex, a number of large mature secretory granules, a few protogranules and many small clear vesicles. Macular gap junctions couple the JG cells to each other, to neighbouring Goormaghtigh cells, and to smooth muscle cells further upstream of the afferent arteriole [S, 201. There are about 5-20 JG cells in each afferent arteriole, but the number varies considerably and depends on several factors (reviewed by Taugner and Hackenthal [S] such as the location in the kidney (some authors have reported a higher renin content in cortical than in juxtamedullary arterioles), the age (in fetal life the renin-positive segment extends as far as the arcuate arteries but after partus the arterial tree quickly attains the adult renin profile [25] ), the salt balance (a low-sodium diet increases the renin-positive segment of the afferent arteriole) and certain pathophysiological conditions [S] . Finally, various medications, such as ACE inhibitors and high doses of diuretics, are associated with excessive renin production and extension of JG cells upstream towards the cortical radiate artery. The plasticity of the renin-producing segment of the afferent arteriole thus enables the RAS to adapt to the differing demands on the secretory capacity. The cellular mechanism responsible for the metaplastic transformation is not known yet, but it may involve transforming growth factor-P2, which accumulates in JG apparatuses of mice after stimulation of the renin system [26] .
The afferent arteriole forms a part of the JG apparatus. This complex is formed by (a) the two glomerular arterioles, (b) a specialized plaque of tubular epithelial cells called the macula densa [27] , which is located in the wall of the thick ascending limb of Henle at the point where the tubule returns to its parent glomerulus, and (c) modified interstitial cells (Goormaghtigh cells/extraglomerular mesangium) which fill out the space between the glomerular tuft and the macula densa [28] .
INTRACELLULAR REGULATION OF RENIN SECRETION Calcium in JG cells
By an elegant combination of whole-cell patch clamp and measurements of intracellular calcium concentrations, Kurtz and Penner [29] have yielded new information about the regulation of the intracellular calcium concentration of JG cells. The concentration of free ionized calcium in the cytosol of the resting JG cell is around 50-100nmol/l, and it can be increased transiently by the mobilization of calcium from intracellular stores and by the opening of calcium channels in the cell membrane. Receptor activation (e.g. by ANG 11) may stimulate both mechanisms.
The mechanism of hormone-activated release of calcium from the intracellular stores of JG cells has many similarities with that known for other cells. Receptor activation stimulates phospholipase C (PLC) enzyme activity by means of a presumed regulatory G-protein. Activated PLC then liberates inositol trisphosphate (IP,) and diacylglycerol (DAG) from phospholipids located on the inside of the cell membrane. DAG causes stimulation of protein kinase C, whose influence on renin release is only sparsely elucidated. IP, diffuses through the cytoplasm to the intracellular stores (probably the endoplasmic reticulum) where it causes release of calcium. This release may oscillate [29] . Depolarization of the membrane potential reduces the frequency of the oscillations in calcium release. In this way receptor-agonist interactions and electrical events may act in concert to regulate the intracellular calcium concentration. After receptor activation a transmembrane calcium entry pathway is important for the increased level of calcium in the steady-state that follows the initial oscillations. On the other hand, it has not been possible with this direct technique to provide evidence for the existence of voltage-operated calcium channels in JG cells [30] . This contrasts with a considerable amount of indirect evidence from experiments where pharmacological blockage of voltage-dependent calcium channels has affected renin release from a variety of preparations [31] . The reason for this apparent inconsistency remains unknown. Increases in extracellular calcium concentration in the millimolar range increase the frequency of oscillations in intracellular calcium concentration by a mechanism that probably involves generation of IP, [29] .
In summary, the calcium concentration of renal JG cells is influenced by intracellular liberation mediated by second messengers and by influx through receptor-activated channels in the cell membrane. The JG cell membrane potential and the extracellular calcium concentration may modify the primary calcium-mobilizing events.
Calcium and renin secretion
There is a large amount of experimental evidence The JG cells possess calcium-activated chloride channels [29] . Because the membrane potential of JG cells is in the vicinity of -70 to -80mV and the equilibrium potential of chloride is probably about -30 mV, activation of these channels, and of potassium channels, leads to efflux of chloride and potassium. Water follows for osmotic reasons and the JG cells (and their organelles) must shrink. A similar mechanism is known from other cells where it is involved in cell volume regulation. Since renin release is sensitive to water fluxes (see below), this ability of intracellular calcium to influence the cell volume of JG cells through activation of chloride channels may play a role in the control of renin secretion [34] . Another hypothesis focuses on the existence of a subcortical network of myofilaments [35] , and proposes that an increased calcium concentration contracts the myofilaments which then prevent contact between secretory granules and the cell membrane. Results from isolated glomeruli suggest that the stimulation of renin release caused by a low external calcium concentration involves both an anion-sensitive mechanism and recruitment of secretory granules to the cell membrane [36] . Thus, calcium may affect renin release by several mechanisms.
Cyclic AMP
Stimulation of the membrane-bound enzyme adenylate cyclase followed by generation of cyclic AMP from cytosolic ATP is an important step in the stimulus-response coupling of many different cellular systems. Depending on the cell type, cyclic AMP acts as a stimulator or as an inhibitor of secretion. The intracellular effects of cyclic AMP include activation of protein kinases and interference with calcium metabolism. In JG cells receptor-mediated stimulation of adenylate cyclase (nerve stimulation, p-adrenoceptor agonists) acts to increase the intracellular concentration of cyclic AMP and results in stimulation of renin secretion. Augmentation of renin secretion is also observed when the level of cyclic AMP is increased experimentally, independently of receptor activation (reviewed in [20] ). On the other hand, cyclic AMP is not an obligatory second messenger because renin release can also be stimulated independently of cyclic AMP [37] . A possible mechanism for the stimulatory effect of cyclic AMP on renin release has been proposed recently by the demonstration that the calciumliberating effect of IP, is suppressed by the concomitant presence of cyclic AMP in the cytosol [29] . Moreover, if calcium is increased experimentally then cyclic AMP is no longer able to enhance secretion. Viewed together, these findings suggest that cyclic AMP may modulate renin release indirectly by effects on calcium regulation.
Cyclic GMP
Cyclic G M P is generated from cellular GTP by membrane-bound or soluble guanylate cyclase in a manner analogous to that of cyclic AMP generation. Cyclic G M P is a potent vasodilator and is produced intracellularly by smooth muscle cells which have been stimulated by endothelium-derived relaxing factor (EDRF), atrial natriuretic peptide or nitroprusside. Many secretory processes are stimulated by cyclic GMP. Conditions of increased levels of cyclic G M P in renal JG cells often correlate with inhibition of renin secretion [38] , but reports of no change in, or stimulation of, renin release also exist [20] . Consequently, the available experimental evidence is in favour of an inhibitory role for cyclic G M P in renin secretion, but the reports are more conflicting and sparse than those documenting the effects of cyclic AMP.
Osmotic forces
Secretion of renin from JG cells is highly sensitive to changes in extracellular osmolality [39, 401. Thus, exposure of JG cells in vitro to acute hypoosmolality is associated with an increased frequency of renin discharges, and with swelling of secretory granules, adjoinment of secretory granules with the cell membrane and areas of fusion [21, 411. Hyperosmolality inhibits secretion. Osmotic changes brought about by non-permeant solutes are more efficient in inducing renin release than permeant solutes. This implies that volume variations in JG cells and/or their organelles (e.g. secretory granules) influence the secretory response.
In several cell types extensive granular swelling occurs after fusion between the secretory granule and the cell membrane has been established without changing the medium osmolality [42] . This swelling, which probably results from volume phase transition of the granule matrix, may be necessary for the stabilization and dilatation of the fusion pore and thereby assists in content extrusion. Because extracellular hypo-osmolality causes increased secretion in JG cells, water flux must stimulate secretion from JG cells by a mechanism that precedes the fusion between granule and cell membrane. In J G cells with permeabilized cell membranes cell volume changes are avoided, but the osmotic sensitivity is maintained (B. L. Jensen and 0. Skertt, unpublished work). This suggests a role for water fluxes between cytosol and the granules in the late steps of exocytosis.
Ion channels and carriers of the JG cells
The JG cells share basic electrophysiological properties with most other cells. The resting membrane potential is thus about -70 to -80mV, and is primarily a potassium diffusion potential. Wholecell patch-clamp experiments on JG cells have allowed the identification of two different types of voltage-dependent potassium channels. One is activated by depolarization (to -lOmV or more positive potentials) and allows potassium to flow out of the cell (delayed outward rectifier), whereas the other is activated by hyperpolarization and lets potassium into the cell (anomalous inward rectifier). By such direct experiments it has not been possible to identify voltage-dependent channels for calcium or sodium [29, 301 . Increases in the intracellular calcium concentration of the J G cells lead to the opening of chloride channels [29] . Thus, any stimulus to the cells that causes the intracellular calcium concentration to increase (e.g. ANG 11, antidiuretic hormone, a-adrenoceptor stimulation) also causes an increase in chloride conductance and thereby depolarization of the cells, and probably also cell shrinkage. The precise significance of these channeis in the control of renin secretion has not been determined with certainty.
Indirect experiments where renin secretion was measured after treatment of JG cell preparations with different chemical agents have suggested the existence in the J G area of anion-exchange mechanisms (HCO;/Cl- [43] ), a Na+/H+ exchange mechanism [44] , which is probably activated by protein kinase C, a Na+/Ca2 + exchange mechanism [3 11 and voltage-dependent calcium channels [3 11. Blockers of Na+/K+/2Cl-co-transport (loop diuretics) have no direct effect on the JG cells and their acute stimulatory effect on renin release in intact kidneys is probably mediated by the macula densa [45, 461. It may be concluded that JG cells have many similarities with other cells as regards electrophysiological properties and ion translocation mechanisms. Activation of some mechanisms may influence renin secretion (e.g. calcium channels); others probably have 'house-keeping' functions in the cells, including volume regulation, while for most of them, a definitive role in the control of secretion has not been resolved.
INTRARENAL MECHANISMS OF RENIN SECRETION
In keeping with the complex homoeostatic role of the RAS, renin secretion is under physiological control by a number of mechanisms. Release is stimulated by decreases in arteriolar pressure, by increases in the activity of the renal nerves, and by a signal originating in the tubular fluid at the macula densa, and it is probably also influenced by the local concentrations of a variety of substances, including prostaglandins, catecholamines, ANG I1 and adenosine.
Renal baroreceptor mechanism
A reduction in the renal blood perfusion pressure by partial clamping of the renal artery leads to a renin-dependent hypertension, which is probably similar to the pathological conditions observed with renal artery stenosis [47, 481. In experiments with both anaesthetized and conscious dogs, it has been demonstrated that stepwise reductions in the renal arterial perfusion pressure lead to an increase in renin release before detectable changes in renal blood flow or glomerular filtration rate occur [49, SO]. These results suggest the existence of a renal baroreceptor which stimulates renin release when the renal perfusion pressure drops. Similar results from experiments on dogs with denervated, nonfiltering kidneys suggest that the phenomenon is independent of the macula densa mechanism and renal nerve activity [5 11. The relationship between renin secretion and the perfusion pressure is not linear: secretion increases steeply when the perfusion pressure is decreased below 90mmHg (i.e. only a little below the mean arterial blood pressure). Stimulation of the renal nerves causes an increase in the sensitivity of the baroreceptor mechanism: a smaller drop in perfusion pressure is necessary to stimulate renin release when the renal nerve activity is increased or when the postsynaptic receptors are stimulated pharmacologically with a-adrenoceptor agonists [52] . This nerve-mediated effect on threshold pressure may be involved in the pathogenesis of congestive heart failure, where early sympathetic activation has been suggested to cause reninmediated volume retention [SO] .
The precise intrarenal mechanism that is responsible for the pressure sensitivity is unknown, but is generally assumed to include a vascular receptor located in the wall of the afferent arteriole, which is stimulated by a drop in wall tension. The wall tension depends on both the transmural pressure gradient and the arteriolar diameter. This is in accordance with the observed stimulation of renin secretion when the transmural pressure declines [drop in perfusion pressure or increase in interstitial pressure (ureteral obstruction)] and when the arteriolar diameter is increased without a concomitant decrease in pressure [53] . The baroreceptor mechanism has been suggested to involve stretch-sensitive cells in the arteriolar wall. Direct tests of this hypothesis on isolated pressurized afferent arterioles have given conflicting results [54, 551.
Clamping of the renal artery in the intact kidney is accompanied by marked changes in salt excretion even before glomerular filtration rate is changed. In spite of the results from non-filtering kidneys, the macula densa mechanism may, therefore, contribute to the effects on renin release observed after the reduction in the renal perfusion pressure.
Macula densa mechanism
The close anatomical relationship between the macula densa and the renin-containing cells in the afferent arteriole led Goormaghtigh [56] more than 50 years ago to propose that the glomerular circulation is automatically regulated by the composition of the urine passing the macula densa plaque. In later papers he focused on renin as a local constrictor of the glomerular arterioles and the glomerular tuft [57] . As regards the direction of change in renin secretion after variations in NaCl concentration at the macula densa two antithetic views were argued in the early 1960s: according to Thurau [SS] , an increase in distal NaCl concentration should stimulate renin secretion, whereas Vander and Miller [59] and Leyssac [60] believed the opposite to be true. Most investigations on whole kidneys have supported the latter view, whereas most single-nephron studies have supported the former. In one micropuncture study it was reported though, that a decreased flow through the loop of Henle caused an increase in renin concentration in both efferent arteriolar plasma and in proximal tubular fluid of microperfused nephron (a low tubular flow causes a drop in NaCl concentration at the macula densa) Consensus about the issue has emerged after the appearance of a technique in vitro by which single JG apparatuses were microdissected from rabbits and the tubule segment containing the macula densa was perfused, while simultaneously the entire JG apparatus was superfused and the fluid was collected for renin measurement [62] . Results from this preparation have shown that a low NaCl concentration at the macula densa stimulates renin release and vice versa. The effect is reversible and is independent of osmolality. Luminal application of loop diuretics mimics the effect of low NaCl, implying that it is the transport rate of NaCl across the apical membrane of the macula densa cells which determines the renin secretory response. In this preparation in vitro, the maximal sensitivity to variations in NaCl concentration is within the phyw 1 . siological range (25-60 mmol/l). Ion substitution experiments suggest that chloride is more important than sodium for the macula densa response [46, 62, 631. It is not yet known how the signal is transmitted from the macula densa to the JG cells, although several hypotheses exist. One hypothesis suggests that an increased reabsorptive rate by the macula densa leads to an increased breakdown of ATP and thereby increased formation of adenosine which, in turn, should inhibit renin release [64] . Several independent investigators have shown that stimulation of adenosine-1 receptors inhibits renin release [64] , and adenosine-1 antagonists are able to attenuate the inhibition seen with high luminal NaCl in the isolated perfused JG apparatus [65] . Another hypothesis takes into consideration that the J G interstitium is poor in capillary and lymphatic drainage, and that the macula densa has a relatively low water permeability [66] . Consequently, the composition (osmolality?) of the interstitial fluid may be influenced by the macula densa transport rate of NaCl. Variations in osmolality could directly influence the secretion rate from the JG cells [40] . In the Amphiuma kidney it has been shown that the interstitial chloride concentration around the JG cells increases in direct proportion to an increased perfusion rate through the distal tubule towards the glomerular region [67] . The local production of prostaglandins may also play a role, and the coupling by gap junctions among Goormaghtigh cells makes it possible that an electrical signal could be involved.
Renal nerves and renin secretion
The renal blood vessels and tubular structures, including the JG apparatus, are innervated by sympathetic nerves which mainly contain noradrenaline. Activation of the renal nerves has multiple effects: vasoconstriction, reduced glomerular filtration rate, increased proximal tubular fluid reabsorption and enhanced renin secretion [S] .
The afferent renal nerves have been stimulated directly by application of depolarizing current pulses, and indirectly by compression of the carotid artery which activates the sinus caroticum and is followed by an elevated sympathetic outflow. Stimulation of the renal nerves in either way leads to an augmented renin secretory activity. The renin secretory response is observed even at low levels of nerve stimulation that have no effects on vascular tonus, tubular function or glomerular filtration rate. The increase in renin secretion is inhibited by Padrenoceptor antagonists or by denervation [68- 701. Consistent with this, renin release from a number of preparations in uitro is stimulated by Padrenoceptor agonists. In isolated renin-producing cells the production of cyclic AMP increased in response to 8-adrenoceptor agonists. Altogether there is good evidence that P-adrenoceptors are located on the J G cells and that they operate by activation of adenylate cyclase [71] .
The transmitter substance of the sympathetic nerve terminals is noradrenaline, which is known to stimulate both a-and P-adrenoceptors. Treatment of JG cells with low concentrations of noradrenaline leads to an enhanced renin release, which can be inhibited by P-adrenoceptor antagonists. Higher concentrations of noradrenaline have been reported to decrease renin secretion from preparations of J G cells in uitro in a manner that can be inhibited by aadrenoceptor antagonists. The a-adrenoceptormediated decrease in secretion rate is probably mediated by an increase in intracellular calcium concentration. In the integrated organism the renin secretory response of a-adrenoceptor stimulation is the opposite, probably because of secondary effects by a-adrenoceptor stimulation on renal haemodynamics, tubular reabsorption and the release of locally acting hormones (e.g. prostaglandins) [70] .
Other putative transmitters have been discovered in renal nerve endings, and some of these might affect renin release. In other systems some of the substances have been shown to activate adenylate cyclase (dopamine, vasoactive intestinal peptide, calcitonin-gene-related peptide), whereas others have been reported to inhibit adenylate cyclase (neuropeptide Y). Any physiological role for these substances in the control of renin secretion remains to be established [20] .
Endothelial factors
The identification of the endothelial cell layer as a production site of vasoconstrictors (endothelins) and vasodilators (EDRF/NO) has focused attention on the possible involvement of these factors in the local control of renin secretion.
Endothelin inhibits basal or stimulated renin release from a number of preparations in uitro, probably by a direct effect on the JG cells [72-741. Infusion of endothelin into intact dogs is followed by stimulation of renin release, but this is associated with a drop in renal blood flow and may well be mediated indirectly [75] . Infusion of low levels of endothelin in man did not affect plasma renin levels
The effect of EDRF/NO is less clear cut. Perfusate from carotid arteries treated with acetylcholine to stimulate N O production inhibits renin release from dog kidney slices [77] , and blockage of N O formation stimulated renin release from rat renal cortical slices [78] and in awake dogs [79] . By contrast, blockage of N O formation reduces renin release in intact anaesthetized rats [SO] , isolated perfused kidneys [8 11 and co-cultures of endothelial cells and mouse JG cells [74] . Thus, the effect of N O on renin release is currently completely unresolved. A complex interplay between the different endothelial factors (endothelin, NO, prostaglandins) is likely to exist [74, 781. ~761.
The physiological role of endothelin and EDRF/ NO in the control of renin secretion is unknown; it is tempting to suggest a role in baroreceptormediated renin release, and the existence of NO synthase in macula densa cells suggests involvement in the macula densa mechanism as well [82] .
Humoral factors
A multitude of hormones, cytokines and neurotransmitters affect renin release, but in many cases it has been difficult to define precisely the role of a humoral substance. Different routes of administration in various preparations probably result in varying concentrations of the agents around the JG cells, and the complex interaction of different control systems may also contribute to conflicting results.
Hormones that interact with adenylate cyclasecoupled receptors and augment the intracellular concentration of cyclic AMP cause stimulation of renin release. This group of agents comprises /?-adrenoceptor agonists and prostaglandins. Histamine also stimulates adenylate cyclase by interaction with H,-receptors, but whether this response is direct, or whether it is mediated by the macula densa mechanism or the endothelial cells has not been resolved. Furthermore, the physiological role of histamine in renin release is not clear. Hormones which inhibit adenylate cyclase generally inhibit renin secretion. Thus adenosine interacts with A,-receptors on the JG cells to cause inhibition of renin release [8, 203.
The kidney proximal tubules have the ability to decarboxylate circulating L-dopa producing dopamine. Activation of this endogenous dopamine production by infusion of the dopamine precursor y-Lglutamyl-L-dopa reduces the plasma renin activity in humans. The type of dopamine receptor that mediates this inhibition has not been elucidated [83] . On the other hand, infusion of dopamine itself into humans causes a stimulation of renin release which is mediated by DA,-receptors [84]. A similar stimulation by dopamine mediated by DA,-receptors has been seen in a number of experiments in vivo and in vitro [84, 851. Thus, most evidence suggests that infused dopamine acts on DA,-receptors on JG cells to stimulate renin release, whereas endogenous dopamine produced by the proximal tubules may have the opposite effect.
The cellular effect of agents which increase the intracellular calcium concentration (ANG 11, endothelin, antidiuretic hormone, a-adrenoceptor agonists) is the inhibition of renin release. ANG I1 interacts with specific receptors and activates calcium channels and initiates generation of IP,, which causes liberation of calcium from intracellular stores. In addition, the transcriptional rate of the renin gene is also suppressed by ANG 11. These direct effects of ANG I1 act together to cause a tonic inhibition of renin secretion. This is uncovered when the formation of ANG I1 is inhibited (ACE inhibitors) and renin secretion and synthesis increase to reach high levels [86] . In addition, ANG I1 has an indirect inhibitory effect on renin release by inducing a rise in blood pressure and by the saltretaining effect of aldosterone. Systemic ANG I1 reaches the kidney via the bloodstream, but, in addition, local generation of ANG I1 is likely to occur because both renin substrate and ACE are present in the renal interstitium. ANG I1 has even been demonstrated within the secretory granules of JG cells, but it is not clear whether it is taken up from the interstitium or whether it is produced intracellularl y.
Antidiuretic hormone does not seem to play a significant physiological role in renin release [8, 201.
In the kidney activation of the calcium-sensitive enzyme phospholipase A, causes liberation of arachidonic acid from the cell membrane, and initiates, thereby, synthesis of prostaglandins, leukotrienes and thromboxane. The kidney vasculature produces predominantly prostacyclin, and the renal medulla generates prostaglandin E,. The enzyme cyclooxygenase, which is responsible for the production of prostaglandins from arachidonic acid, has been demonstrated immunohistochemically in the arteriolar endothelium, in glomeruli and in mesangial cells [87]. Prostaglandins may thus be produced locally and thereby affect renin release. Experiments in uitro and in vivo have demonstrated that renin release is stimulated by prostaglandins and that the effect is due to a direct interaction with the JG cells [88] . The most potent stimulation is seen after treatment with prostacyclin, which increases the intracellular concentration of cyclic AMP by activation of adenylate cyclase. Prostaglandins have been suggested to mediate one or the other of the physiological regulators of renin release (baroreceptor, macula densa, nerve stimulation), but each mechanism can function independently of the prostaglandin system and, therefore, an obligatory role is not likely. On the other hand, activation of each of the integrated mechanisms leads to an increase in prostaglandin production which may feed back on the JG cells and modulate the final response to the primary signal. Anaesthesia and surgery lead to an increase in prostaglandin production, which may lead to overestimation of the role played by prostaglandins. Lipoxygenase products (leukotrienes) are also probably synthesized locally, and inhibitory effects on renin release of some of the metabolites and a possible interplay with the cyclo-oxygenase products have been reported [89] , but the possible relevance to the physiological control of renin secretion remains speculative.
The kallikrein-kinin system is active in the kidney. The end product, bradykinin, influences vascular resistance, blood pressure and kidney function in the opposite direction to the RAS. Biochemically, the two systems are closely linked, since the same enzyme, ACE, is responsible for the generation of ANG I1 and the breakdown of bradykinin. Furthermore, kallikrein is capable of activating prorenin. Kallikrein has even been reported to stimulate renin release directly. The physiological interplay between these two systems is potentially important, but is still unresolved [20] .
Atrial natriuretic peptide is a 28-amino acid peptide which is produced by the heart and reaches the kidney via the bloodstream. According to most reports, atrial natriuretic peptide inhibits renin secretion and is associated with an increased production of cyclic GMP. There exist, however, many contradictory findings, and no consensus has emerged about the physiological significance of atrial natriuretic peptide in the control of renin secretion [20] . Recently, a kidney-derived natriuretic factor, the 32-amino acid peptide urodilatin, has been isolated from urine [90] . Its effect on renin secretion is unknown.
CONCLUSIONS
Renal renin is synthesized, stored and released from cells located in the afferent glomerular arteriole. The initial transcriptional product is preprorenin. Cleaving off the pre-segment leaves prorenin, which is glycosylated and passed through the Golgi apparatus. From here, it is either secreted immediately or stored in secretory granules where activation occurs by removal of the pro-segment. The secretion of granules is regulated and takes place by exocytosis. Important intracellular signal molecules include calcium, which probably inhibits secretion, and cyclic AMP, which stimulates secretion. In addition, osmotic water movements also play a role.
The physiological regulation involves a complex interplay that involves the following mechanisms: (1) a baroreceptor, since lowered perfusion pressure to the kidney stimulates renin release; (2) a tubular signal, since a decrease in the chloride concentration at the macula densa stimulates renin release; (3) the nerve supply to the kidney, which stimulates secretion directly via P-adrenoceptors on the J G cells, and also indirectly via the influence of c1-adrenoceptors on haemodynamics and tubular resorption; (4) local and circulating hormones, particularly ANG I1 and prostaglandins.
